Search Results - "Acket, B."

Immune-related adverse events after immune checkpoints inhibitors in 2019: An update by Comont, T, Belliere, J, Sibaud, V, Alric, L, Meyer, N, Mazières, J, Caron, P, Acket, B, Michot, J-M, Beyne-Rauzy, O, Lambotte, O

“…Use of checkpoint inhibitors to treat cancer was one of the most important revolution these last years and an increasing number of new types of tumors is…”
Get full text

Ultrasonographic anatomy of the long thoracic nerve: A reappraisal using high frequency (24-MHz) probe by Faruch Bilfeld, M., Lapègue, F., Cintas, P., Acket, B., Basselerie, H., Bachour, R., Nougarolis, F., Ricard, C., Chiavassa Gandois, H., Laumonerie, P., Aprodoaei, C., Sans, N.

“…•The long thoracic nerve can be examined with ultrasound above the clavicle and along the chest wall.•Ultrasound is a highly reproducible technique to…”
Get full text

Use of Antidepressant Medications To Improve Outcomes After Stroke by Chollet, F., Acket, B., Raposo, N., Albucher, J. F., Loubinoux, I., Pariente, J.

“…Interest in the use of antidepressants after stroke has been renewed by better knowledge of poststroke depression, but mainly by the capacity of some of them…”
Get full text

Monoaminergic drugs for motor recovery after ischemic stroke by Chollet, F, Tardy, J, Albucher, J.-F, Raposo, N, Acket, B, Sattler, V, Pariente, J, Loubinoux, I

“…Abstract Today, administering rTPA thrombolytic therapy within the first hours of a stroke is the only validated drug therapy for improving the spontaneous…”
Get full text

Effect of repeated sessions of combined anodal tDCS and peripheral nerve stimulation on motor performance in acute stroke: A behavioural and electrophysiological study by Sattler, V, Acket, B, Gerdelat-Mas, A, Raposo, N, Albucher, J.-F, Thalamas, C, Loubinoux, I, Chollet, F, Simonetta-Moreau, M

Get full text

Effet sur la récupération motrice post-AVC, en phase aiguë, de sessions répétées de tDCS anodale du cortex moteur primaire couplée à une stimulation électrique périphérique répétitive by Sattler, V, Acket, B, Gerdelat-Mas, A, Raposo, N, Albucher, J.-F, Thalamas, C, Loubinoux, I, Chollet, F, Simonetta-Moreau, M

Get full text

Real‐life effectiveness 1 year after switching to avalglucosidase alfa in late‐onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study by Tard, Céline, Bouhour, Françoise, Michaud, Maud, Beltran, Stephane, Fournier, Maxime, Demurger, Florence, Lagrange, Emmeline, Nollet, Sylvain, Sacconi, Sabrina, Noury, Jean‐Baptiste, Magot, Armelle, Cintas, Pascal, Renard, Dimitri, Deibener‐Kaminsky, Joëlle, Lefeuvre, Claire, Davion, Jean‐Baptiste, Salort‐Campana, Emmanuelle, Arrassi, Azzeddine, Taouagh, Nadjib, Spinazzi, Marco, Orlikowski, D, Masingue, M, Stojkovic, T, Béhin, A, Garcia, PY, Lallement, F, Bassez, G, Germain, D, Kouton, L, Verschueren, A, Furby, A, Kaminsky, AL, Lacour, A, Praline, J, Sole, G, Duval, F, Bouibede, F, Chapon, F, Minot, MC, Hubert, J, Pereon, Y, Acket, B, Nadaj‐Pakleza, A, Morales, RJ, Esselin, F, Petiot, P, Jaussaud, R, Mohamed, S, Echaniz‐Laguna, YA, Magy, L, Krim, E, Taithe, F, Bedat‐Millet, AL, Toquet, S, Diab, E, Maillet‐Vioud, M, Attarian, Shahram, Laforêt, Pascal

“…Introduction Late‐onset Pompe disease (LOPD) is characterized by a progressive myopathy resulting from a deficiency of acid α‐glucosidase enzyme activity…”
Get full text

Validation of an helicoidal versus standard ankle-foot orthosis for patients with unilateral drop foot by Gasq, D., Acket, B., Caussé, B., Cantagrel, N., Combe, E., Cintas, P., Arné-Bes, M.C.

“…Patients with drop foot commonly use ankle-foot orthosis (AFO) as walking aid, but the impact on gait abilities of the orthosis design is still unclear. The…”
Get full text

NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY by Morales, R. Juntas, Cances, C., Cintas, P., Renard, D., Sole, G., Espil, C., Rivier, F., Louvier, U. Walther, Uro-Coste, E., Perrin, A., Leboucq, N., Rigau, V., Arne-Bes, M., Duval, F., Acket, B., Peyroulan, D., Theze, C., Pegeot, H., Cossee, M.

Get full text

NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.372Next generation sequencing: new phenotype-genotype correlations by Morales, R. Juntas, Cances, C., Cintas, P., Renard, D., Sole, G., Espil, C., Rivier, F., Louvier, U. Walther, Uro-Coste, E., Perrin, A., Leboucq, N., Rigau, V., Arne-Bes, M., Duval, F., Acket, B., Peyroulan, D., Theze, C., Pegeot, H., Cossee, M.

Get full text

Progressive multifocal leukoencephalopathy in a patient with alcoholic cirrhosis by Acket, B., Guillaume, M., Tardy, J., Dumas, H., Sattler, V., Bureau, C.

Get full text

Toxicités immunologiques induites par les inhibiteurs de checkpoint en 2019 : mise au point by Comont, T., Belliere, J., Sibaud, V., Alric, L., Meyer, N., Mazières, J., Caron, P., Acket, B., Michot, J.-M., Beyne-Rauzy, O., Lambotte, O.

“…Les inhibiteurs de points de contrôle immunitaire ont révolutionné la prise en charge thérapeutique de nombreux cancers permettant des gains de survie globale…”
Get full text

Immune-related adverse events after immune checkpoints inhibitors in 2019: An update by Comont, T, Belliere, J, Sibaud, V, Alric, L, Meyer, N, Mazières, J, Caron, P, Acket, B, Michot, J-M, Beyne-Rauzy, O, Lambotte, O

Get full text

U - 3 Ataxie-tremblement liée à l’X fragile chez 2 frères : apport de l’IRM au diagnostic by Debs, R., Acket, B., Cognard, C.

“…Le diagnostic génétique de l’ataxie-tremblement lié à l’X fragile est récent. Nous rapportons le cas de deux frères suivis pendant dix ans, présentant des…”
Get full text

H - 1 Syndrome cérébelleux des anti Yo répondant au Rituximab en relation avec un adénocarcinome pulmonaire by Acket, B., Debs, R., Fabre, N., Slaoui, T., Geraud, G.

“…Les syndromes cérébelleux paranéoplasiques des anti-Yo sont des affections rares, en majorité liés à un cancer gynécologique. Nous rapportons le cas d’anti-yo…”
Get full text

Progressive multifocal leukoencephalopathy in a patient with alcoholic cirrhosis by Acket, B, Guillaume, M, Tardy, J, Dumas, H, Sattler, V, Bureau, C

Get full text